UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?

Circulation (New York, N.Y.), 2018-07, Vol.138 (2), p.150-153

Koenig, Wolfgang

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population

Circulation (New York, N.Y.), 2005-08, Vol.112 (5), p.651-657

2005

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular biomarkers: added value with an integrated approach?

Circulation (New York, N.Y.), 2007-07, Vol.116 (1), p.3-5

Koenig, Wolfgang

2007

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein modulates risk prediction based on the framingham score. Implications for future risk assessment: Results from a large cohort study in Southern Germany

Circulation (New York, N.Y.), 2004-03, Vol.109 (11), p.1349-1353

2004

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from southern Germany

Circulation (New York, N.Y.), 2004-10, Vol.110 (14), p.1903-1908

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract 11033: Efficacy and Safety of Inclisiran by Baseline Glycemic Status: A Post Hoc Pooled Analysis of the ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 11143: Efficacy and Safety of Inclisiran by Baseline Body Mass Index: A Post Hoc Pooled Analysis of the ORION-9, ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Circulation (New York, N.Y.), 2021-11, Vol.144 (Suppl_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

Circulation (New York, N.Y.), 2008-09, Vol.118 (11), p.1172-1182

2008

Link zum Volltext

Verfügbarkeit prüfen

Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

Circulation (New York, N.Y.), 2024-02, Vol.149 (9), p.669

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

Circulation (New York, N.Y.), 2010-03, Vol.121 (12), p.1382-1392

2010

Link zum Volltext

Verfügbarkeit prüfen

High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography

Circulation (New York, N.Y.), 2010-03, Vol.121 (10), p.1227-1234

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 21: Deciphering the Plasma Proteome of Type 2 Diabetes

Circulation (New York, N.Y.), 2020-03, Vol.141 (Suppl_1)

2020

Link zum Volltext

Verfügbarkeit prüfen

From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II

Circulation (New York, N.Y.), 2003-10, Vol.108 (15), p.1772-1778

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract 16311: Efficacy and Safety of Inclisiran According to Sex: A Pooled Analysis of the ORION 9, 10 and 11 Trials

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A16311-A16311

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 16427: Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11)

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A16427-A16427

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract P206: The Risk for Cardiovascular Disease Attributable to Traditional Risk Factors Increases

Circulation (New York, N.Y.), 2018-03, Vol.137 (suppl_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

Circulation (New York, N.Y.), 2022, Vol.146 (20), p.1507-1517

2022

Link zum Volltext

Verfügbarkeit prüfen

From Vulnerable plaque to Vulnerable patient: A call for new definitions and risk assessment strategies: Part I

Circulation (New York, N.Y.), 2003-10, Vol.108 (14), p.1664-1672

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract P195: The Relative Contribution of Systolic Blood Pressure in Cardiovascular Risk Prediction Declines

Circulation (New York, N.Y.), 2017-03, Vol.135 (suppl_1)

2017

Link zum Volltext

Verfügbarkeit prüfen

Aspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model

Circulation (New York, N.Y.), 2001-03, Vol.103 (12), p.1688-1694

2001

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone reduces neointima volume after coronary stent implantation : A randomized, placebo-controlled, double-blind trial in nondiabetic patients

Circulation (New York, N.Y.), 2005-11, Vol.112 (18), p.2792-2798

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract P285: Frequency of Sexual Activity the Year before Myocardial Infarction and Risk for Subsequent Cardiovascular Adverse Events: Results of a Long-Term Follow-Up Study

Circulation (New York, N.Y.), 2015-03, Vol.131 (suppl_1)

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease

Circulation (New York, N.Y.), 2003-04, Vol.107 (15), p.1954-1957

2003

Link zum Volltext

Verfügbarkeit prüfen

Abstract MP05: N Terminal Pro B Type Natriuretic Peptide as a Stroke Risk Factor in the European Population: Results From the Biomarcare Consortium

Circulation (New York, N.Y.), 2018-03, Vol.137 (suppl_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P008: Ultra-Sensitive Troponin I Strongly Predicts Incident Coronary Heart Disease in the General Population Independently of Traditional Risk Factors. Results From the MONICA/KORA Augsburg Case-Cohort Study

Circulation (New York, N.Y.), 2014-03, Vol.129 (suppl_1)

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Archive Collection A-Z Listing

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(22)
Cardiac & Cardiovascular Systems
(21)
Cardiovascular System & Cardiology
(21)
Life Sciences & Biomedicine
(21)
Peripheral Vascular Disease
(21)
Science & Technology
(21)
Male
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Cardiology. Vascular System
(15)
Female
(14)
Middle Aged
(14)
Coronary Disease
(12)
Heart
(12)
Risk Factors
(12)
Coronary Heart Disease
(11)
Blood And Lymphatic Vessels
(10)
Aged
(9)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(8)
Coronary Disease - Epidemiology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population

Cardiovascular biomarkers: added value with an integrated approach?

C-reactive protein modulates risk prediction based on the framingham score. Implications for future risk assessment: Results from a large cohort study in Southern Germany

Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: Results from the 14-year follow-up of a large cohort from southern Germany

Abstract 11033: Efficacy and Safety of Inclisiran by Baseline Glycemic Status: A Post Hoc Pooled Analysis of the ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Abstract 11143: Efficacy and Safety of Inclisiran by Baseline Body Mass Index: A Post Hoc Pooled Analysis of the ORION-9, ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis

Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium

High-Sensitivity Troponin T Concentrations in Acute Chest Pain Patients Evaluated With Cardiac Computed Tomography

Abstract 21: Deciphering the Plasma Proteome of Type 2 Diabetes

From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II

Abstract 16311: Efficacy and Safety of Inclisiran According to Sex: A Pooled Analysis of the ORION 9, 10 and 11 Trials

Abstract 16427: Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11)

Abstract P206: The Risk for Cardiovascular Disease Attributable to Traditional Risk Factors Increases

Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

From Vulnerable plaque to Vulnerable patient: A call for new definitions and risk assessment strategies: Part I

Abstract P195: The Relative Contribution of Systolic Blood Pressure in Cardiovascular Risk Prediction Declines

Aspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model

Pioglitazone reduces neointima volume after coronary stent implantation : A randomized, placebo-controlled, double-blind trial in nondiabetic patients

Abstract P285: Frequency of Sexual Activity the Year before Myocardial Infarction and Risk for Subsequent Cardiovascular Adverse Events: Results of a Long-Term Follow-Up Study

Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease

Abstract MP05: N Terminal Pro B Type Natriuretic Peptide as a Stroke Risk Factor in the European Population: Results From the Biomarcare Consortium

Abstract P008: Ultra-Sensitive Troponin I Strongly Predicts Incident Coronary Heart Disease in the General Population Independently of Traditional Risk Factors. Results From the MONICA/KORA Augsburg Case-Cohort Study

Aktive Filter

Suchergebnisse filtern